Therapeutic experience with fludrocortisone in diabetic postural hypotension

Br Med J. 1976 Apr 10;1(6014):872-4. doi: 10.1136/bmj.1.6014.872.

Abstract

Fourteen patients with diabetic postural hypotension were treated with fludrocortisone for a mean 12 months (range 6-30 months). The mean daily dose of fludrocortisone was 0.2 mg (range 0.1 mg-0.4 mg). Standing systolic and diastolic blood pressures increased significantly (P less than 0.001) after treatment with fludrocortisone and the postural hypotension decreased significantly (P less than 0.001). Thirteen patients noted considerable symptomatic improvement. Fludrocortisone should be used cautiously in patients with congestive cardiac failure or the nephrotic syndrome.

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Aged
  • Blood Pressure
  • Clinical Trials as Topic
  • Diabetic Neuropathies / drug therapy*
  • Dose-Response Relationship, Drug
  • Female
  • Fludrocortisone / therapeutic use*
  • Heart Failure / complications
  • Humans
  • Hypotension, Orthostatic / complications
  • Hypotension, Orthostatic / drug therapy*
  • Male
  • Middle Aged
  • Nephrotic Syndrome / complications

Substances

  • Fludrocortisone